{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:34:02Z","timestamp":1771655642750,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s10620-020-06050-7","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T05:05:37Z","timestamp":1580447137000},"page":"2483-2491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Retrograde Transvenous Obliteration (RTO): A New Treatment Option for Hepatic Encephalopathy"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0418-1454","authenticated-orcid":false,"given":"Edward Wolfgang","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sammy","family":"Saab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen T.","family":"Kee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,31]]},"reference":[{"key":"6050_CR1","first-page":"222","volume":"7","author":"RT Frederick","year":"2011","unstructured":"Frederick RT. Current concepts in the pathophysiology and management of hepatic encephalopathy. Gastroenterol Hepatol. 2011;7:222\u2013233.","journal-title":"Gastroenterol Hepatol"},{"key":"6050_CR2","first-page":"480309","volume":"2012","author":"Z Poh","year":"2012","unstructured":"Poh Z, Chang PE. A current review of the diagnostic and treatment strategies of hepatic encephalopathy. Int J Hepatol. 2012;2012:480309.","journal-title":"Int J Hepatol"},{"key":"6050_CR3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrgastro.2010.116","volume":"7","author":"R Prakash","year":"2010","unstructured":"Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol. 2010;7:515\u2013525.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6050_CR4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mpmed.2006.11.003","volume":"35","author":"NC McAvoy","year":"2007","unstructured":"McAvoy NC, Hayes PC. Hepatic encephalopathy. Medicine. 2007;35:108\u2013111.","journal-title":"Medicine"},{"key":"6050_CR5","first-page":"RA53","volume":"17","author":"GT Toris","year":"2011","unstructured":"Toris GT, Bikis CN, Tsourouflis GS, Theocharis SE. Hepatic encephalopathy: an updated approach from pathogenesis to treatment. Med Sci Monit Int Med J Exp Clin Res. 2011;17:RA53\u2013RA63.","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"6050_CR6","first-page":"143","volume":"27","author":"RF Butterworth","year":"2003","unstructured":"Butterworth RF. Hepatic encephalopathy\u2013a serious complication of alcoholic liver disease. Alcohol Res Health J Natl Inst Alcohol Abus Alcohol. 2003;27:143\u2013145.","journal-title":"Alcohol Res Health J Natl Inst Alcohol Abus Alcohol"},{"key":"6050_CR7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4254\/wjh.v4.i3.50","volume":"4","author":"JC Perazzo","year":"2012","unstructured":"Perazzo JC, Tallis S, Delfante A, et al. Hepatic encephalopathy: an approach to its multiple pathophysiological features. World J Hepatol. 2012;4:50\u201365.","journal-title":"World J Hepatol"},{"key":"6050_CR8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3748\/wjg.v19.i1.26","volume":"19","author":"H Cichoz-Lach","year":"2013","unstructured":"Cichoz-Lach H, Michalak A. Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy. World J Gastroenterol WJG. 2013;19:26\u201334.","journal-title":"World J Gastroenterol WJG"},{"key":"6050_CR9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","volume":"35","author":"P Ferenci","year":"2002","unstructured":"Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy\u2013definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th world congresses of gastroenterology, Vienna, 1998. Hepatology. 2002;35:716\u2013721.","journal-title":"Hepatology"},{"key":"6050_CR10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep.20703","volume":"41","author":"J Polson","year":"2005","unstructured":"Polson J, Lee WM. American association for the study of liver D. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179\u20131197.","journal-title":"Hepatology"},{"key":"6050_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10620-007-9895-0","volume":"53","author":"TI Hassanein","year":"2008","unstructured":"Hassanein TI, Hilsabeck RC, Perry W. Introduction to the hepatic encephalopathy scoring algorithm (HESA). Dig Dis Sci. 2008;53:529\u2013538. https:\/\/doi.org\/10.1007\/s10620-007-9895-0.","journal-title":"Dig Dis Sci"},{"key":"6050_CR12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1365-2036.2007.03394.x","volume":"26","author":"M Ortiz","year":"2007","unstructured":"Ortiz M, Cordoba J, Doval E, et al. Development of a clinical hepatic encephalopathy staging scale. Aliment Pharmacol Ther. 2007;26:859\u2013867.","journal-title":"Aliment Pharmacol Ther"},{"key":"6050_CR13","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/j.1572-0241.2001.03964.x","volume":"96","author":"AT Blei","year":"2001","unstructured":"Blei AT, Cordoba J. Practice parameters committee of the American college of G. hepatic encephalopathy. Am J Gastroenterol. 2001;96:1968\u20131976.","journal-title":"Am J Gastroenterol"},{"key":"6050_CR14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.26370","volume":"58","author":"P Amodio","year":"2013","unstructured":"Amodio P, Bemeur C, Butterworth R, et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis: international society for hepatic encephalopathy and nitrogen metabolism consensus. Hepatology. 2013;58:325\u2013336.","journal-title":"Hepatology"},{"key":"6050_CR15","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/bmj.38048.506134.EE","volume":"328","author":"B Als-Nielsen","year":"2004","unstructured":"Als-Nielsen B, Gluud LL, Gluud C. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ. 2004;328:1046.","journal-title":"BMJ"},{"key":"6050_CR16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","volume":"60","author":"H Vilstrup","year":"2014","unstructured":"Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver. Hepatology. 2014;60:715\u2013735.","journal-title":"Hepatology"},{"key":"6050_CR17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/SGA.0000000000000429","volume":"42","author":"DM Zucker","year":"2019","unstructured":"Zucker DM, Redulla R. Lactulose management of minimal hepatic encephalopathy: a systematic review. Gastroenterol Nurs. 2019;42:84\u201394.","journal-title":"Gastroenterol Nurs"},{"key":"6050_CR18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000346083","volume":"87","author":"J Wen","year":"2013","unstructured":"Wen J, Liu Q, Song J, Tong M, Peng L, Liang H. Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial. Digestion. 2013;87:132\u2013138.","journal-title":"Digestion"},{"key":"6050_CR19","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/jgh.13666","volume":"32","author":"BC Sharma","year":"2017","unstructured":"Sharma BC, Singh J, Srivastava S, et al. Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy. J Gastroenterol Hepatol. 2017;32:1234\u20131239.","journal-title":"J Gastroenterol Hepatol"},{"key":"6050_CR20","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/gutjnl-2014-308521","volume":"64","author":"S Maharshi","year":"2015","unstructured":"Maharshi S, Sharma BC, Srivastava S, Jindal A. Randomised controlled trial of lactulose versus rifaximin for prophylaxis of hepatic encephalopathy in patients with acute variceal bleed. Gut. 2015;64:1341\u20131342.","journal-title":"Gut"},{"key":"6050_CR21","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/MEG.0b013e32834d1938","volume":"23","author":"M Luo","year":"2011","unstructured":"Luo M, Li L, Lu CZ, Cao WK. Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis. Eur J Gastroenterol Hepatol. 2011;23:1250\u20131257.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6050_CR22","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ajg.2012.113","volume":"107","author":"A Agrawal","year":"2012","unstructured":"Agrawal A, Sharma BC, Sharma P, Sarin SK. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. Am J Gastroenterol. 2012;107:1043\u20131050.","journal-title":"Am J Gastroenterol"},{"key":"6050_CR23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/j.gastro.2009.05.056","volume":"137","author":"BC Sharma","year":"2009","unstructured":"Sharma BC, Sharma P, Agrawal A, Sarin SK. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology. 2009;137:885\u2013891.","journal-title":"Gastroenterology"},{"key":"6050_CR24","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1440-1746.2012.07186.x","volume":"27","author":"P Sharma","year":"2012","unstructured":"Sharma P, Sharma BC, Agrawal A, Sarin SK. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose. J Gastroenterol Hepatol. 2012;27:1329\u20131335.","journal-title":"J Gastroenterol Hepatol"},{"key":"6050_CR25","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","volume":"362","author":"NM Bass","year":"2010","unstructured":"Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362:1071\u20131081.","journal-title":"N Engl J Med"},{"key":"6050_CR26","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/ajg.2013.219","volume":"108","author":"BC Sharma","year":"2013","unstructured":"Sharma BC, Sharma P, Lunia MK, Srivastava S, Goyal R, Sarin SK. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol. 2013;108:1458\u20131463.","journal-title":"Am J Gastroenterol"},{"key":"6050_CR27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1051-0443(07)61912-5","volume":"12","author":"T Fukuda","year":"2001","unstructured":"Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol JVIR. 2001;12:327\u2013336.","journal-title":"J Vasc Interv Radiol JVIR"},{"key":"6050_CR28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1440-1746.1996.tb00010.x","volume":"11","author":"H Kanagawa","year":"1996","unstructured":"Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 1996;11:51\u201358.","journal-title":"J Gastroenterol Hepatol"},{"key":"6050_CR29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1148\/radiology.211.2.r99ma25349","volume":"211","author":"S Hirota","year":"1999","unstructured":"Hirota S, Matsumoto S, Tomita M, Sako M, Kono M. Retrograde transvenous obliteration of gastric varices. Radiology. 1999;211:349\u2013356.","journal-title":"Radiology"},{"key":"6050_CR30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3348\/kjr.2003.4.2.109","volume":"4","author":"YH Choi","year":"2003","unstructured":"Choi YH, Yoon CJ, Park JH, Chung JW, Kwon JW, Choi GM. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J Radiol Off J Korean Radiol Soc. 2003;4:109\u2013116.","journal-title":"Korean J Radiol Off J Korean Radiol Soc"},{"key":"6050_CR31","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1440-1746.2008.05549.x","volume":"23","author":"T Akahoshi","year":"2008","unstructured":"Akahoshi T, Hashizume M, Tomikawa M, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. J Gastroenterol Hepatol. 2008;23:1702\u20131709.","journal-title":"J Gastroenterol Hepatol"},{"key":"6050_CR32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jvir.2010.11.022","volume":"22","author":"SS Sabri","year":"2011","unstructured":"Sabri SS, Swee W, Turba UC, et al. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vasc Interv Radiol JVIR. 2011;22:309\u2013316.","journal-title":"J Vasc Interv Radiol JVIR"},{"key":"6050_CR33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1148\/radiol.13122102","volume":"268","author":"DI Gwon","year":"2013","unstructured":"Gwon DI, Ko GY, Yoon HK, et al. Gastric varices and hepatic encephalopathy: treatment with vascular plug and gelatin sponge-assisted retrograde transvenous obliteration\u2014a primary report. Radiology. 2013;268:281\u2013287.","journal-title":"Radiology"},{"key":"6050_CR34","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1038\/ctg.2014.12","volume":"5","author":"EW Lee","year":"2014","unstructured":"Lee EW, Saab S, Gomes AS, et al. Coil-assisted retrograde transvenous obliteration (CARTO) for the treatment of portal hypertensive variceal bleeding: preliminary results. Clin Transl Gastroenterol. 2014;5:e61.","journal-title":"Clin Transl Gastroenterol"},{"key":"6050_CR35","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s10620-014-3485-8","volume":"60","author":"JK Park","year":"2014","unstructured":"Park JK, Saab S, Kee ST, et al. Balloon-occluded retrograde transvenous obliteration (BRTO) for treatment of gastric varices: review and meta-analysis. Dig Dis Sci. 2014;60:1543\u20131553. https:\/\/doi.org\/10.1007\/s10620-014-3485-8.","journal-title":"Dig Dis Sci"},{"key":"6050_CR36","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00270-017-1869-9","volume":"41","author":"HH Chu","year":"2018","unstructured":"Chu HH, Kim M, Kim HC, Lee JH, Jae HJ, Chung JW. Long-term outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices: a comparison of ethanolamine oleate and sodium tetradecyl sulfate. Cardiovasc Interv Radiol. 2018;41:578\u2013586.","journal-title":"Cardiovasc Interv Radiol"},{"key":"6050_CR37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-0031-1284457","volume":"28","author":"SS Sabri","year":"2011","unstructured":"Sabri SS, Saad WE. Balloon-occluded retrograde transvenous obliteration (BRTO): technique and intraprocedural imaging. Semin Interv Radiol. 2011;28:303\u2013313.","journal-title":"Semin Interv Radiol"},{"key":"6050_CR38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2169\/internalmedicine.40.677","volume":"40","author":"A Toyonaga","year":"2001","unstructured":"Toyonaga A, Oho K. Should B-RTO be the first-line treatment for portosystemic encephalopathy? Intern Med. 2001;40:677\u2013678.","journal-title":"Intern Med"},{"key":"6050_CR39","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12328-014-0495-1","volume":"7","author":"Z Baimakhanov","year":"2014","unstructured":"Baimakhanov Z, Soyama A, Takatsuki M, et al. Effective balloon-occluded retrograde transvenous obliteration of the superior mesenteric vein-inferior vena cava shunt in a patient with hepatic encephalopathy after living donor liver transplantation. Clin J Gastroenterol. 2014;7:342\u2013345.","journal-title":"Clin J Gastroenterol"},{"key":"6050_CR40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jvir.2006.10.002","volume":"18","author":"K Ibukuro","year":"2007","unstructured":"Ibukuro K, Sugihara T, Tanaka R, et al. Balloon-occluded retrograde transvenous obliteration (BRTO) for a direct shunt between the inferior mesenteric vein and the inferior vena cava in a patient with hepatic encephalopathy. J Vasc Interv Radiol JVIR. 2007;18:121\u2013125.","journal-title":"J Vasc Interv Radiol JVIR"},{"key":"6050_CR41","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jvir.2012.05.046","volume":"23","author":"A Mukund","year":"2012","unstructured":"Mukund A, Rajesh S, Arora A, Patidar Y, Jain D, Sarin SK. Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience. J Vasc Interv Radiol JVIR. 2012;23:1200\u20131206.","journal-title":"J Vasc Interv Radiol JVIR"},{"key":"6050_CR42","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/hep.26314","volume":"57","author":"W Laleman","year":"2013","unstructured":"Laleman W, Simon-Talero M, Maleux G, et al. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology. 2013;57:2448\u20132457.","journal-title":"Hepatology"},{"key":"6050_CR43","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41395-018-0109-5","volume":"113","author":"EW Lee","year":"2018","unstructured":"Lee EW, Saab S, Kaldas F, et al. Coil-assisted retrograde transvenous obliteration (CARTO): an alternative treatment option for refractory hepatic encephalopathy. Am J Gastroenterol. 2018;113:1187.","journal-title":"Am J Gastroenterol"},{"key":"6050_CR44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00042737-200101000-00015","volume":"13","author":"K Takada","year":"2001","unstructured":"Takada K, Homma H, Takahashi M, et al. A case of successful management of portosystemic shunt with autosomal dominant polycystic kidney disease by balloon-occluded retrograde transvenous obliteration and partial splenic embolization. Eur J Gastroenterol Hepatol. 2001;13:75\u201378.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6050_CR45","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.jvir.2015.07.011","volume":"26","author":"DI Gwon","year":"2015","unstructured":"Gwon DI, Kim YH, Ko GY, et al. Vascular plug-assisted retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy: a prospective multicenter study. J Vasc Interv Radiol JVIR. 2015;26:1589\u20131595.","journal-title":"J Vasc Interv Radiol JVIR"},{"key":"6050_CR46","first-page":"391420","volume":"2014","author":"JK Park","year":"2014","unstructured":"Park JK, Cho SK, Kee S, Lee EW. Vascular plug-assisted retrograde transvenous obliteration of portosystemic shunts for refractory hepatic encephalopathy: a case report. Case Rep Radiol. 2014;2014:391420.","journal-title":"Case Rep Radiol"},{"key":"6050_CR47","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-0031-1284460","volume":"28","author":"WE Saad","year":"2011","unstructured":"Saad WE, Sabri SS. Balloon-occluded retrograde transvenous obliteration (BRTO): technical results and outcomes. Semin Interv Radiol. 2011;28:333\u2013338.","journal-title":"Semin Interv Radiol"},{"key":"6050_CR48","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s00270-015-1288-8","volume":"39","author":"YH Kim","year":"2016","unstructured":"Kim YH, Kim YH, Kim CS, Kang UR, Kim SH, Kim JH. Comparison of balloon-occluded retrograde transvenous obliteration (BRTO) using ethanolamine oleate (EO), BRTO using sodium tetradecyl sulfate (STS) foam and vascular plug-assisted retrograde transvenous obliteration (PARTO). Cardiovasc Interv Radiol. 2016;39:840\u2013846.","journal-title":"Cardiovasc Interv Radiol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06050-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-020-06050-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06050-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T00:22:18Z","timestamp":1611966138000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-020-06050-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["6050"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06050-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,31]]},"assertion":[{"value":"1 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No financial conflict-of-interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}